Predictions
Express Inc.
Start price
Target price
Perf. (%)
€6.05
26.06.21
26.06.21
-
26.06.22
26.06.22
-66.07%
27.06.22
27.06.22
Probably not worthwhile Investment
Beyond Air Inc.
Start price
Target price
Perf. (%)
€5.92
26.06.21
26.06.21
-
26.06.22
26.06.22
2.67%
27.06.22
27.06.22
Could be very worthwhile Investment >20% year
Ashford Hospitality Trust Inc.
Start price
Target price
Perf. (%)
€45.05
26.06.21
26.06.21
-
26.06.22
26.06.22
-86.90%
27.06.22
27.06.22
Could be worthwhile Investment >10% per year
Syros Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€46.00
26.06.21
26.06.21
-
26.06.22
26.06.22
-81.82%
27.06.22
27.06.22
Could be very worthwhile Investment >20% year
Gtt Communications Inc
Start price
Target price
Perf. (%)
€2.70
26.06.21
26.06.21
-
26.06.22
26.06.22
-25.93%
27.06.22
27.06.22
Probably not worthwhile Investment
Synchronoss Technologies
Start price
Target price
Perf. (%)
€3.00
26.06.21
26.06.21
€1.00
26.06.22
26.06.22
-12.00%
10.07.21
10.07.21
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Below average Management
Bad culture
Freightcar America
Start price
Target price
Perf. (%)
€5.30
26.06.21
26.06.21
€3.00
26.06.22
26.06.22
-0.94%
10.07.21
10.07.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
Express Inc.
Start price
Target price
Perf. (%)
€6.05
26.06.21
26.06.21
€3.00
26.06.22
26.06.22
-21.65%
10.07.21
10.07.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
CGX Energy Inc.
Start price
Target price
Perf. (%)
€1.51
26.06.21
26.06.21
€0.000
26.06.22
26.06.22
-29.14%
10.07.21
10.07.21
Low dividend yield expected
negative Cash Flow expected
Little Investments for future growth
Risky balance sheet
Osmotica Pharmaceuticals PLC
Start price
Target price
Perf. (%)
€3.04
26.06.21
26.06.21
€1.00
26.06.22
26.06.22
-18.42%
10.07.21
10.07.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Carmax Inc.
Start price
Target price
Perf. (%)
€107.00
25.06.21
25.06.21
-
25.06.22
25.06.22
5.61%
30.12.21
30.12.21
Revenue growth >5% per year expected
Growths faster than the competition
Very low/no dividend yield expected
Atossa Genetics Inc
Start price
Target price
Perf. (%)
€7.20
25.06.21
25.06.21
-
25.06.22
25.06.22
-26.39%
30.06.21
30.06.21
Could be very worthwhile Investment >20% year
CrowdStrike Holdings Inc
Start price
Target price
Perf. (%)
€210.65
25.06.21
25.06.21
€230.00
25.06.22
25.06.22
15.31%
04.11.21
04.11.21
Could be worthwhile Investment >10% per year
Top 10 in its market
Future proof or reliable business model
Some uniques
Hannover Rück SE ADR
Start price
Target price
Perf. (%)
€70.50
25.06.21
25.06.21
€75.00
25.06.22
25.06.22
-4.26%
26.06.22
26.06.22
Could be worthwhile Investment >10% per year
AMC Entertainment Holdings Inc.
Start price
Target price
Perf. (%)
€47.30
25.06.21
25.06.21
-
17.06.22
17.06.22
-17.32%
25.08.21
25.08.21
Standard Investments for future growth
Valuable balance sheet
Normal challenges to pay loans and raise capital
Probably not worthwhile Investment
Orphazyme A/S
Start price
Target price
Perf. (%)
€6.80
25.06.21
25.06.21
-
21.06.22
21.06.22
-88.60%
22.06.22
22.06.22
EBIT growth >5% per year expected
Capable Management
Few uniques
Dependend from some customers or products
Orphazyme A/S
Start price
Target price
Perf. (%)
€0.78
25.06.21
25.06.21
-
21.06.22
21.06.22
-
25.06.21
25.06.21
EBIT growth >5% per year expected
Capable Management
Few uniques
Dependend from some customers or products
BioNTech SE ADR
Start price
Target price
Perf. (%)
€192.00
25.06.21
25.06.21
-
25.06.22
25.06.22
24.64%
23.07.21
23.07.21
Could be worthwhile Investment >10% per year
Neoen S.a.
Start price
Target price
Perf. (%)
€36.06
24.06.21
24.06.21
€33.00
24.06.22
24.06.22
-7.93%
16.09.21
16.09.21
Could be worthwhile Investment >10% per year
Gaussin S.A.
Start price
Target price
Perf. (%)
€7.75
24.06.21
24.06.21
-
21.06.22
21.06.22
-50.94%
22.06.22
22.06.22
Revenue growth >5% per year expected
Good rating
ROE higher than 10% per year
Risky balance sheet
Anterix Inc.
Start price
Target price
Perf. (%)
€52.50
24.06.21
24.06.21
€48.00
24.06.22
24.06.22
-26.10%
25.06.22
25.06.22
Could be worthwhile Investment >10% per year